NRIP1 and Alzheimer disease: RIP140 acts as a critical cofactor for PPARγ, and activation of PPARγ has been shown to reduce Aβ levels both in vitro and in animal models of AD by downregulating the transcription of BACE1, a key enzyme involved in Aβ production.